23 related articles for article (PubMed ID: 12520735)
1. Bcl-X(L) antisense sensitizes human colon cancer cell line to 5-fluorouracil.
Nita ME; Ono-Nita SK; Tsuno N; Tominaga O; Takenoue T; Sunami E; Kitayama J; Nakamura Y; Nagawa H
Jpn J Cancer Res; 2000 Aug; 91(8):825-32. PubMed ID: 10965024
[TBL] [Abstract][Full Text] [Related]
2. [Design of antisense oligodeoxynucleotide targeting at bcl-2 mRNA and observation on its effect on the sensitivity of leukemia cells to arabinosyl cytosine].
Lei XY; Zhang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):41-4. PubMed ID: 12667288
[TBL] [Abstract][Full Text] [Related]
3. Enforced expression of Bcl-XS induces differentiation and sensitizes chronic myelogenous leukemia-blast crisis K562 cells to 1-beta-D-arabinofuranosylcytosine-mediated differentiation and apoptosis.
Ray S; Bullock G; Nuñez G; Tang C; Ibrado AM; Huang Y; Bhalla K
Cell Growth Differ; 1996 Dec; 7(12):1617-23. PubMed ID: 8959329
[TBL] [Abstract][Full Text] [Related]
4. [A novel bcl-2 antisense oligodeoxynucleotide F951 increases sensitivity of HL-60 cells to Ara-C].
Li DL; Lu LH; Chen YY; Lin ZX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):752-6. PubMed ID: 15631654
[TBL] [Abstract][Full Text] [Related]
5. [Apoptosis of human gastric cancer cells induced by bcl-2 antisense oligodeoxynucleotides].
Lu P; Chen J
Zhonghua Zhong Liu Za Zhi; 1999 Jul; 21(4):253-5. PubMed ID: 11776807
[TBL] [Abstract][Full Text] [Related]
6. Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN.
Jahrsdörfer B; Jox R; Mühlenhoff L; Tschoep K; Krug A; Rothenfusser S; Meinhardt G; Emmerich B; Endres S; Hartmann G
J Leukoc Biol; 2002 Jul; 72(1):83-92. PubMed ID: 12101266
[TBL] [Abstract][Full Text] [Related]
7. Modulation of ara-C induced apoptosis in leukemia by the PKC activator bryostatin 1.
Grant S
Front Biosci; 1997 Jun; 2():d242-52. PubMed ID: 9195893
[TBL] [Abstract][Full Text] [Related]
8. Ara-C: cellular and molecular pharmacology.
Grant S
Adv Cancer Res; 1998; 72():197-233. PubMed ID: 9338077
[TBL] [Abstract][Full Text] [Related]
9. Bcl-2-related antisense therapy.
Gutiérrez-Puente Y; Zapata-Benavides P; Tari AM; López-Berestein G
Semin Oncol; 2002 Jun; 29(3 Suppl 11):71-6. PubMed ID: 12138400
[TBL] [Abstract][Full Text] [Related]
10. Application of antisense technology to urologic cancers.
Tomita Y
Mol Urol; 2000; 4(2):55-9. PubMed ID: 12006243
[TBL] [Abstract][Full Text] [Related]
11. [Bcl-2 antisense oligodeoxynucleotide enhances araninosyl cytosine-induced apoptosis of primary leukemia cells].
Lei XY; Zhang H; He DM
Ai Zheng; 2002 Dec; 21(12):1301-4. PubMed ID: 12520735
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
